CD4 and psoriasis: In this sense, it has been shown that, after BS, the inflammatory profile and the disproportionate inflammatory activity of T cells (CD4+ and CD8+), Th1/Th2, and B cells decreases significantly [154]; these changes can directly ameliorate low-grade systemic inflammation and, therefore, position BS as a tool for the treatment and prevention of psoriasis in obese patients.